Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Malini Surapaneni"'
Autor:
Malini Surapaneni, Dipesh Uprety
Publikováno v:
International Journal of Cancer Care and Delivery.
Lung cancer is the second-most prevalent cancer and, the most common cause of cancer-related mortality throughout the world. Evidence-based strategies to decrease its incidence and mortality are being implemented in different parts of the world. Smok
Publikováno v:
Expert review of hematology. 15(5)
Chronic myeloid leukemia is now a highly treatable leukemia due to the availability of multiple tyrosine kinase inhibitors (TKIs) inhibiting the BCR-ABL1 oncogene. Some patients with CML can display resistance or intolerance to multiple TKIs, oftenti
Autor:
Malini Surapaneni, Abhinav Deol, Seongho Kim, Voravit Ratanatharathorn, Joseph P. Uberti, Dipenkumar Modi, Lois Ayash
Publikováno v:
Leukemia & Lymphoma. 61:3137-3145
Anti-thymocyte globulin (ATG) targets in-vivo T lymphocytes. Variations in the recipient absolute lymphocyte count (ALC) might result in a variable exposure of ATG. We hypothesized that recipient ALC on the first day of ATG might predict transplant o
Autor:
Seongho Kim, Abhinav Deol, Dipenkumar Modi, Asif Alavi, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti, Malini Surapaneni
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:683-690
Allogeneic stem cell transplant (alloSCT) is considered in diffuse large B cell lymphoma (DLBCL) patients with chemorefractory disease or who have relapsed after autologous SCT. Here we present the first report of alloSCT using the R-BEAM (rituximab,
Autor:
Malini Surapaneni, Samer Alkassis, Seongho Kim, Abhinav Deol, Lois Ayash, Asif Alavi, Andrew Kin, Voravit Ratanatharathorn, Joseph Uberti, Dipenkumar Modi
Publikováno v:
Transplantation and Cellular Therapy. 28:S206-S207
Autor:
Michael Steven Simon, Nadine Abdallah, Hadeel Assad, Malini Surapaneni, Rachel Reagle, Nancie Petrucelli, Kristen Purrington
Publikováno v:
Cancer Research. 80:P6-08
Background There are racial and ethnic differences in the prevalence and types of pathogenic mutations and variants of uncertain significance (VUS) in BRCA1 and BRCA2. Since the landmark May 13, 2013 Supreme Court Ruling invalidating the patent for B
Autor:
Rachel Reagle, Nadine Abdallah, Nancie Petrucelli, Hadeel Assad, Kristen S. Purrington, Malini Surapaneni, Michael S. Simon
Publikováno v:
Cancer Research. 80:P6-08
Background It is estimated that up to 10% of women diagnosed with breast cancer in the United States have a BRCA1 or BRCA2 inherited susceptibility, which accounts for approximately 125,000 women. There are racial and ethnic differences in the preval
Autor:
Hyejeong Jang, Jing Christine Ye, Dipenkumar Modi, Abhinav Deol, Lois Ayash, Asif Alavi, Malini Surapaneni, Joseph P. Uberti, Vijendra Singh, Voravit Ratanatharathorn, Wei Chen
Publikováno v:
Am J Hematol
Liver Graft-versus-host disease (GVHD) is common in patients with post-transplant liver dysfunction following allogeneic hematopoietic stem cell transplantation (AHSCT). Oftentimes, the diagnosis is made clinically, and liver biopsy is deferred. Our
Autor:
Voravit Ratanatharathorn, Samer Alkassis, Abhinav Deol, Seongho Kim, Andrew Kin, Asif Alavi, Dipenkumar Modi, Malini Surapaneni, Lois Ayash, Joseph P. Uberti
Publikováno v:
Blood. 138:4812-4812
Introduction: CD19 directed CAR-T cell therapy has changed treatment paradigm of relapse refractory diffuse large B cell lymphoma (DLBCL). It is associated with certain unique toxicities including cytokine release syndrome (CRS), immune effector cell
Autor:
Hyejeong Jang, Hirva Mamdani, Malini Surapaneni, Ibrahim Azar, Daniel Kurtz, Syed Mehdi, Adam Austin, Amit Chopra, Omid Yazdanpanah, Seongho Kim
Publikováno v:
Journal of Clinical Oncology. 39:8565-8565
8565 Background: Standard of care therapy for LS- SCLC is concurrent chemo-radiation (CRT) with a platinum-etoposide backbone. Cisplatin is traditionally the preferred platinum agent in the curative intent setting. Data comparing the efficacy of the